Clinical Trial Update: Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation [NA]

View source ↗

Summary

Trial evaluating Blinatumomab as maintenance therapy for high-risk B-cell acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: B-ALL | NA | Status: NOT_YET_RECRUITING